Cerus reported $43.02M in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Atrion ATRI:US 40.29M 2.56M
Cerus CERS:US $ 43.02M 7.07M
GRIFOLS GRF:SM € 1351.9M 167.16M
Haemonetics HAE:US $ 265M 5.23M
Meridian Bioscience VIVO:US $ 111.23M 22.89M
Nuvasive NUVA:US $ 290.76M 11.31M
Orasure Technologies OSUR:US $ 67.71M 4.14M
Quidel QDEL:US $ 1002.26M 365.39M
Sientra SIEN:US $ 21.4M 1.25M
Staar Surgical STAA:US $ 63.2M 4.2M
Terumo 4543:JP Y 179821M 977M
Utah Medical Products UTMD:US $ 12.57M 1.61M